Astressin, a novel and potent CRF antagonist, is neuroprotective in the hippocampus when administered after a seizure
Open Access
- 2 January 1997
- journal article
- Published by Elsevier in Brain Research
- Vol. 744 (1) , 166-170
- https://doi.org/10.1016/s0006-8993(96)01207-3
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Stress, Glucocorticoids, and Damage to the Nervous System: The Current State of ConfusionStress, 1996
- Early development of cerebellar afferent systems that contain corticotropin‐releasing factorJournal of Comparative Neurology, 1994
- CRF and Related Peptides as Anti‐Inflammatory AgonistsaAnnals of the New York Academy of Sciences, 1993
- Sympathetic Activity Enhances Glucose-related Ischemic Injury in the RatAnesthesiology, 1993
- Corticotropin‐releasing hormone–induced seizures in infant rats originate in the amygdalaAnnals of Neurology, 1992
- Ganglionic Blockade Improves Neurologic Outcome from Incomplete Ischemia in RatsAnesthesiology, 1990
- Localized Epileptiform Activity Induced by Murine CRF in RatsEpilepsia, 1988
- Circulating Catecholamines Modulate Ischemic Brain DamageJournal of Cerebral Blood Flow & Metabolism, 1986
- Improved Neurological Outcome in Expermental Focal Cerebral Ischemia Treated with PropranololNeurosurgery, 1986
- Corticotropin Releasing Factor Decreases Postburst Hyperpolarizations and Excites Hippocampal NeuronsScience, 1983